Biohaven Ltd. — Investor Relations & Filings
Filings indexed
240
across all filing types
Latest filing
2026-05-04
Prospectus
Country
VG
Virgin Islands (British)
Listing
US
BHVN
Biohaven Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies for diseases with significant unmet medical needs. The company's primary therapeutic areas of focus are neuroscience, immunology, and oncology. Biohaven is advancing a portfolio of late- and early-stage drug development programs, building upon its legacy of success in transforming migraine treatment with Nurtec® ODT (rimegepant) and Zavzpret® (zavegepant). The company utilizes proprietary drug development platforms and combines internal research with intellectual property licensed from global institutions to address a broad range of rare and common diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B5 - Biohaven Ltd. (0001935979) (Filer) | 2026-05-04 | English | |
| 4 - Biohaven Ltd. (0001935979) (Issuer) | 2026-03-19 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41064217 | 424B5 - Biohaven Ltd. (0001935979) (Filer) | 2026-05-04 | English | ||
| 32990155 | 4 - Biohaven Ltd. (0001935979) (Issuer) | 2026-03-19 | English | ||
| 32900526 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900525 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900527 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900528 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900529 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900530 | 8-K - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-02 | English | ||
| 32900531 | 10-K - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-02 | English | ||
| 13597694 | 8-K | 2026-01-12 | English | ||
| 13597695 | FORM 4 | 2026-01-08 | English | ||
| 13597697 | FORM 4 | 2026-01-08 | English | ||
| 13597696 | FORM 4 | 2026-01-08 | English | ||
| 13597698 | FORM 4 | 2026-01-08 | English | ||
| 13597699 | FORM 4 | 2026-01-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Biohaven Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31890/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31890 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31890 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31890 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31890}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biohaven Ltd. (id: 31890)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.